ResMed Income from Continuous Operations 2010-2025 | RMD

ResMed annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • ResMed income from continuous operations for the quarter ending June 30, 2025 was $0.380B, a 29.93% increase year-over-year.
  • ResMed income from continuous operations for the twelve months ending June 30, 2025 was $1.401B, a 37.2% increase year-over-year.
  • ResMed annual income from continuous operations for 2025 was $1.401B, a 37.2% increase from 2024.
  • ResMed annual income from continuous operations for 2024 was $1.021B, a 13.75% increase from 2023.
  • ResMed annual income from continuous operations for 2023 was $0.898B, a 15.15% increase from 2022.
ResMed Annual Income from Continuous Operations
(Millions of US $)
2025 $1,401
2024 $1,021
2023 $898
2022 $779
2021 $475
2020 $622
2019 $405
2018 $316
2017 $342
2016 $352
2015 $353
2014 $345
2013 $307
2012 $255
2011 $227
2010 $190
2009 $146
ResMed Quarterly Income from Continuous Operations
(Millions of US $)
2025-06-30 $380
2025-03-31 $365
2024-12-31 $345
2024-09-30 $311
2024-06-30 $292
2024-03-31 $300
2023-12-31 $209
2023-09-30 $219
2023-06-30 $230
2023-03-31 $233
2022-12-31 $225
2022-09-30 $210
2022-06-30 $195
2022-03-31 $179
2021-12-31 $202
2021-09-30 $204
2021-06-30 $195
2021-03-31 $-78
2020-12-31 $180
2020-09-30 $178
2020-06-30 $178
2020-03-31 $163
2019-12-31 $161
2019-09-30 $120
2019-06-30 $69
2019-03-31 $105
2018-12-31 $125
2018-09-30 $106
2018-06-30 $110
2018-03-31 $110
2017-12-31 $10
2017-09-30 $86
2017-06-30 $102
2017-03-31 $88
2016-12-31 $77
2016-09-30 $76
2016-06-30 $83
2016-03-31 $91
2015-12-31 $96
2015-09-30 $83
2015-06-30 $87
2015-03-31 $91
2014-12-31 $91
2014-09-30 $83
2014-06-30 $88
2014-03-31 $90
2013-12-31 $87
2013-09-30 $81
2013-06-30 $73
2013-03-31 $85
2012-12-31 $78
2012-09-30 $71
2012-06-30 $77
2012-03-31 $65
2011-12-31 $63
2011-09-30 $51
2011-06-30 $58
2011-03-31 $53
2010-12-31 $58
2010-09-30 $57
2010-06-30 $53
2010-03-31 $49
2009-12-31 $46
2009-09-30 $42
2009-06-30 $45
2009-03-31 $39
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $41.881B $5.146B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.435B 26.79
Boston Scientific (BSX) United States $153.732B 36.66
Stryker (SYK) United States $149.077B 30.35
EssilorLuxottica (ESLOY) France $146.011B 0.00
Medtronic (MDT) Ireland $115.234B 16.26
Lonza Group Ag (LZAGY) Switzerland $48.493B 0.00
Haleon (HLN) United Kingdom $43.717B 24.97
Agilent Technologies (A) United States $34.119B 22.24
GE HealthCare Technologies (GEHC) United States $33.772B 15.87
Terumo (TRUMY) Japan $27.820B 32.97
Koninklijke Philips (PHG) Netherlands $26.548B 17.56
Insulet (PODD) United States $23.052B 77.24
Zimmer Biomet Holdings (ZBH) United States $20.663B 13.15
Smith & Nephew SNATS (SNN) United Kingdom $16.153B 0.00
Baxter (BAX) United States $12.496B 9.65
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $7.804B 28.67
Lantheus Holdings (LNTH) United States $3.750B 10.14
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.442B 24.08
Perrigo (PRGO) Ireland $3.247B 8.11
Prestige Consumer Healthcare (PBH) United States $3.219B 14.28
ICU Medical (ICUI) United States $3.055B 20.80
Haemonetics (HAE) United States $2.616B 11.68
LeMaitre Vascular (LMAT) United States $2.158B 46.28
QuidelOrtho (QDEL) United States $1.816B 11.43
AtriCure (ATRC) United States $1.781B 0.00
Curaleaf Holdings (CURLF) Canada $1.676B 0.00
Green Thumb Industries (GTBIF) United States $1.566B 67.25
Phibro Animal Health (PAHC) United States $1.291B 16.50
AdaptHealth (AHCO) United States $1.279B 18.17
Neogen (NEOG) United States $1.219B 19.34
Acuren (TIC) United States $1.209B 0.00
BioLife Solutions (BLFS) United States $1.176B 2454.00
Tilray Brands (TLRY) Canada $1.167B 0.00
Valneva SE (VALN) France $0.975B 0.00
InMode (INMD) Israel $0.896B 8.29
Kestra Medical Technologies (KMTS) United States $0.805B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
SNDL (SNDL) Canada $0.552B 0.00
ZimVie (ZIMV) United States $0.534B 20.60
Surmodics (SRDX) United States $0.534B 0.00
Verano Holdings (VRNOF) United States $0.506B 0.00
Cresco Labs (CRLBF) United States $0.501B 0.00
VAREX IMAGING (VREX) United States $0.468B 16.10
Evolus (EOLS) United States $0.461B 0.00
CeriBell (CBLL) United States $0.432B 0.00
Owens & Minor (OMI) United States $0.414B 3.67
Capricor Therapeutics (CAPR) United States $0.351B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanuwave Health (SNWV) United States $0.315B 0.00
Canopy Growth (CGC) Canada $0.300B 0.00
Omeros (OMER) United States $0.297B 0.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Brainsway (BWAY) Israel $0.273B 55.65
Viemed Healthcare (VMD) United States $0.270B 20.44
Aurora Cannabis (ACB) Canada $0.269B 0.00
TerrAscend (TSNDF) Canada $0.262B 0.00
High Tide (HITI) Canada $0.248B 0.00
Quanterix (QTRX) United States $0.234B 0.00
Cerus (CERS) United States $0.228B 0.00
Vireo Growth (VREOF) United States $0.217B 0.00
Exagen (XGN) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.205B 0.00
Organigram Global (OGI) Canada $0.204B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.61
TriSalus Life Sciences (TLSI) United States $0.176B 0.00
FitLife Brands (FTLF) United States $0.157B 19.38
Biote (BTMD) United States $0.149B 4.95
Jushi Holdings (JUSHF) United States $0.103B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Fonar (FONR) United States $0.094B 12.09
Oramed Pharmaceuticals (ORMP) United States $0.084B 0.00
Apyx Medical (APYX) United States $0.075B 0.00
Safety Shot (SHOT) United States $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.053B 31.05
Veru (VERU) United States $0.047B 0.00
Zynex (ZYXI) United States $0.047B 0.00
Nephros (NEPH) United States $0.044B 34.42
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
United-Guardian (UG) United States $0.036B 13.98
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.017B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00